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A B S T R A C T
Production of mycophenolic acid (MPA) by submerged fermentation using the microfungus Penicillium
brevicompactum MTCC 8010 is reported here. Screening experiments were used to identify: the suitable
media composition; the optimal initial pH; and the optimal incubation temperature to maximize the
production of MPA in batch cultures. The initial concentrations of the selected sources of carbon
(glucose), nitrogen (peptone) and the precursors (methionine, glycine) were then optimized by: (1) one-
at-a-time variation of factors; and (2) a central composite design (CCD) of experiments, in a 12-day batch
culture at an initial pH of 5.0, an incubation temperature of 25 C, and an agitation speed of 200 rpm. The
medium optimized using the one-at-a-time variation yielded a peak MPA titer of 1232  90 mg/L. The
medium optimized by the CCD method yielded a 40% higher MPA titer of 1737  55 mg/L. The latter value
was nearly 9-fold greater than the titer achieved prior to optimization.
ã 2016 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Mycophenolic acid (6-(4-hydroxy-6-methoxy-7-methyl-
3oxophthalanyl)-4-methyl-4-hexenic acid, C17H20O6, MPA) is a
fungal secondary metabolite that was ﬁrst isolated in 1893 as an
antibiotic against Bacillus anthracis [1,2]. MPA is produced by many
Penicillium species [3–8] as well as other fungi [6,9]. MPA and its
derivatives are commercially used as frontline immunosuppressive
agents to prevent rejection of transplant organs [10–12]. Commer-
cial immunosuppressants based on MPA include CellCept (myco-
phenolate mofetil; Roche) and Myfortic (mycophenolate sodium;
Novartis). In 2014, the sales of Myfortic were aroundUS$ 543 million
[13]. Similarly, in 2013 US$ 938 million worth of CellCept was sold
[14]. Mycophenolate mofetil in combination with cyclosporine A
(CyA) has been shown to reduce the incidence of graft rejection to
17% compared to a 60% rejection when CyA was used alone.
Here we report on the production of mycophenolic acid (MPA)
by Penicillium brevicompactum MTCC 8010 (Institute of Microbial
Technology, Chandigarh). The batch fermentation conditions are* Corresponding author.
E-mail address: ucbanerjee@niper.ac.in (U.C. Banerjee).
http://dx.doi.org/10.1016/j.btre.2016.07.003
2215-017X/ã 2016 Published by Elsevier B.V. This is an open access article under the Coptimized to maximize the production of MPA. Two optimization
approaches are compared: (1) the conventional one-at-a-time
variation of factors; and (2) a simultaneous variation of the
multiple factors based on a statistically robust central composite
experiment design.
The relevant aspects of biosynthesis of MPA by P. brevicom-
pactum have been discussed in the literature [1,15,16]. The
chemistry, synthesis and modiﬁcations of MPA for improving
the biological activity have been previously reviewed [17]. In
submerged batch fermentations, low-intensity pulsed ultrasound
has enhanced the production of MPA by P. brevicompactum [18].
Production in this fungus may also be inﬂuenced by the intensity
and wavelength of the prevailing light [19], although most
commercial submerged fermentations are inevitably conducted
in the dark. Production of MPA by solid-state fermentation has
been extensively reported in literature [7,20,21], but solid state
fermentations are generally not used for the commercial produc-
tion of medicinal products.C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
78 G. Patel et al. / Biotechnology Reports 11 (2016) 77–852. Materials and methods
2.1. Microorganism and inoculum preparation
The microfungus Penicillium brevicompactum MTCC 8010 used
in this work was obtained from the Institute of Microbial
Technology, Chandigarh, India. The culture was maintained
aseptically on potato dextrose agar (PDA) slants. A spore
suspension was used as inoculum. The spores scarped from the
surface of a slant were transferred to PDA petri plates and
incubated at 25 C for 3-5 days. The spores from the plates were
harvested aseptically with a sterile loop and dispersed in sterile
distilled water to obtain a concentration of 107 spores per milliliter.
A hemocytometer was used for the spore counts.
2.2. Media
The basal medium had the following composition (g/L):
glucose 10, glycine 2, methionine 0.5, KH2PO4 2, MgSO47H2O
1, and 1 mL/L of a trace element solution. The latter contained the
following (g/L): FeSO47H2O 2.2, CuSO45H2O 0.3, ZnSO47H2O 2.4,
MnSO44H2O 0.16, and (NH4)2MoO4 0.2. The media components
except glycine, methionine and trace element solution, were
autoclaved separately at 121 C for 15 min after the pH had been
adjusted to 6.0 with 2 M HCl or 2 M NaOH solutions. Solutions of
glycine, methionine and the trace elements were sterilized using
a sterile 0.2 mm membrane ﬁlter (Millipore; www.emdmillipore.
com).
2.3. Fermentations
Batch fermentations were carried out in 250 mL shake ﬂasks
each containing 50 mL of the culture medium. The medium always
contained the following components (per L): MgSO47H2O 1 and
the trace element solution (1 mL) speciﬁed earlier. This medium
was supplemented with the required concentrations of the
speciﬁed carbon source, the nitrogen source, the phosphate source
and the potential precursors. The initial pH was adjusted to the
required value. This medium (50 mL) was inoculated with 0.5 mL of
the above speciﬁed spore suspension. Incubation occurred at the
speciﬁed temperature. All fermentations were lasted for 12 days.
The agitation speed of the platform shaker was 200 rpm. All
fermentations were run in duplicate.
2.4. Analytical methods
2.4.1. Mycophenolic acid concentration
The MPA concentration was measured in the culture superna-
tant at the end of fermentation. The pH of the ﬁltered supernatant
was adjusted to 2.0 with 1 M HCl. This supernatant (50 mL) was
extracted twice with ethyl acetate (100 mL for each extraction).
The total duration of extraction was 30 min. The organic phase was
recovered, pooled and evaporated at reduced pressure in a rotary
evaporator (Rotavapor, R-200; www.buchi.com). The residue was
dissolved in 1 mL of methanol, ﬁltered through a 0.45 mm ﬁlter and
measured via high performance liquid chromatography (HPLC)
(Waters Alliance HPLC; www.waters.com). A C18 column
(Symmetry1C18, 5 mm, 4.6  250 mm) was used at 40 C. The
mobile phase was water and acetonitrile (50: 50 by vol), pH 3.0, at a
ﬂow rate of 0.5 mL/min. The injection volume was 10 mL. A
photodiode array detector was used at a wavelength of 220 nm
[22].
A standard curve (data not shown) was prepared using HPLC-
grade authentic MPA (Sigma-Aldrich, USA). A HPLC chromatogram
of MPA is shown in Fig. S1. A fresh curve was made each time a
batch of the samples was analyzed. The stock solution of MPA(1 mg/mL) was prepared in methanol and stored at 20 C. When
required, the solution was serially diluted with methanol to
provide MPA concentrations in the range of 2.5–125 mg/mL. All
measurements of MPA were in triplicate.
2.4.2. Glucose concentration
The glucose concentration was measured in the culture
supernatant as reducing sugars by the dinitrosalicylic acid (DNS)
method [23]. A suitably diluted sample (1 mL) was mixed with
1 mL of the DNS reagent, held at 90 C for 10 min, and cooled. The
absorbance was measured at 540 nm against a blank of deionized
water treated the same way as the sample. The measured
absorbance and the dilution factor were used to estimate the
reducing sugar concentration by comparing with a calibration
curve made using dilutions of a standard aqueous solution of
glucose.
2.4.3. Cell mass concentration
The fungal biomass in the fermentation broth was quantiﬁed by
the dry cell weight method. A 50 mL sample of the fermentation
broth was ﬁltered through Grade 50 cheese cloth (purchased from
the local market). The biomass was washed with 50 mL of water
and the resulting cake was dried at 60–65 C for at least 48 h [7,24].
The cake was cooled in a desiccator and weighed.
2.5. Optimization of fermentation medium using one-factor-at-a-time
method
2.5.1. Carbon sources
The speciﬁed carbon sources (glucose, sucrose, fructose,
maltose, lactose, glycerol, xylose, sorbitol, mannitol, starch and
carboxymethyl cellulose) were studied at an initial concentration
of 10 g/L. The carbon source that proved to be the best was
examined further at various initial concentrations in the range
10–100 g/L. The other components of the production medium were
held at the following initial concentrations (g/L): tryptone 5,
glycine 2, methionine 0.5, KH2PO4 2, and MgSO47H2O 1. All media
were supplemented with the earlier speciﬁed solution of trace
elements (1 mL/L). The fermentation conditions were as follows:
27 C; an initial pH of 6.0; an agitation speed of 200 rpm; and a
fermentation duration of 12 days. All fermentations were carried
out in duplicate.
2.5.2. Nitrogen sources
In the screening of the nitrogen sources, the carbon source was
always glucose at an initial concentration of 60 g/L. The various
organic and inorganic nitrogen sources (urea, ammonium nitrate,
tryptone, peptone and asparagine) were screened individually as
nitrogen sources. The initial concentration of a nitrogen source was
always 10 g/L. Peptone was further examined at initial concen-
trations in the range of 10–40 g/L. The other components of the
medium were held at the following initial concentrations (g/L):
glycine 2, methionine 0.5, KH2PO4 2, and MgSO47H2O 1. All media
were supplemented with the earlier speciﬁed solution of trace
elements (1 mL/L). The fermentation conditions were as follows:
27 C; an initial pH of 6.0; an agitation speed of 200 rpm; and a
fermentation duration of 12 days. All fermentations were carried
out in duplicate.
2.5.3. Phosphorous sources
Four different phosphate sources (KH2PO4, K2HPO4, NaH2PO4
and Na2HPO4) were screened individually at an initial concentra-
tion of 6 g/L. The other components of the medium were held at the
following initial concentrations (g/L): glucose 60, peptone 20,
glycine 2, methionine 0.5, and MgSO47H2O 1. All media were
supplemented with the earlier speciﬁed solution of trace elements
Table 1
Concentration ranges of the factors used in central composite design.
Factor Actual levels of coded factors
1 0 +1
Glucose (g/L) 40 60 80
Peptone (g/L) 10 20 30
Methionine (g/L) 1 1.5 2
Glycine (g/L) 4 6 8
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200 rpm agitation speed, and an initial pH of 6.0.
The phosphorous source that proved to be the best was
examined further at various initial concentrations in the range 2–
10 g/L. The other media components and the fermentation
conditions were as speciﬁed above in this section. All fermenta-
tions lasted 12 days and were carried out in duplicate.
2.5.4. The precursors
Methionine is a known precursor of MPA [1,3,25,26]. It is the
main source of the methyl groups in MPA and directly enters the
MPA biosynthesis pathway. Glycine was thought to be a potential
precursor. The effects of the initial concentrations of these two
amino acids on the production MPA and biomass were evaluated
separately. In separate experiments the initial concentration of
methionine was varied in the range of 0–3 g/L. Similarly, the initial
concentration of glycine was varied in the range of 0–12 g/L. The
initial pH value was 6.0 and the incubation temperature was 27 C.
The agitation speed was 200 rpm. All media contained the
following (g/L): glucose 60, peptone 20, KH2PO4 6 and MgSO47H2O
1. The media were supplemented with glycine (2 g/L) in the
experiments in which the initial concentration of methionine was
varied. Otherwise, the media were supplemented with methionine
(1.5 g/L) and the different speciﬁed concentrations of glycine. All
media were supplemented with the earlier speciﬁed solution of
trace elements (1 mL/L). All fermentations were run in duplicate
for 12 days.
2.5.5. The initial pH
The initial medium composition was always as follows (g/L):
glucose 60, peptone 20, glycine 6, methionine 1.5, KH2PO4 6, and
MgSO47H2O 1. All media were supplemented with the earlier
speciﬁed solution of trace elements (1 mL/L). The initial pH was
adjusted to 4–9 in separate experiments. The other fermentation
conditions were ﬁxed as follows: 12 days at 27 C and 200 rpm. All
fermentations were carried out in duplicate.
2.5.6. Incubation temperature
The composition of the fermentation medium was ﬁxed as
speciﬁed above for the pH screening experiments. The initial pH
was 5.0. The fermentations lasted 12 days and the agitation speed
was 200 rpm. The incubation temperature in separate experiments
was varied in the range of 20–35 C. Fermentations were carried
out in duplicate.
2.6. Optimization of the screened factors by a central composite design
The design and analysis of the experiments used the Design-
Expert1 software (Stat-Ease Inc, USA; trial version 9). In view of
the results of the earlier screening experiments, the following
conditions were ﬁxed at the speciﬁed values: an incubation
temperature of 25 C, an incubation time of 12 days, and an initial
pH of 5.0. The medium always contained the following: KH2PO4
6 g/L, MgSO47H2O 1 g/L, and the earlier speciﬁed trace element
solution (1 mL/L). A spore suspension (0.5 mL, 107 spores/mL) was
used to inoculate 50 mL of the culture medium in 250 mL shake
ﬂasks. The ﬂasks were held at 200 rpm. For these conditions, the
following four factors were examined through a central compos-
ite experiment design [7]: the concentrations of glucose, peptone,
methionine and glycine. The concentration ranges of the various
factors are shown in Table 1. The response was the concentration
of mycophenolic acid. A full factorial central composite design
with (24) 16 runs, 6 center points and 8 star points was used. This
led to a total of 30 experiments (Table 2), all performed in
duplicate.2.7. Validation of the response surface model
The predicted optimal values of the factors were identiﬁed
using the response surface model and the point prediction feature
of the Design-Expert1 software. A medium with the predicted
optimal composition was formulated and validation experiments
were run in triplicate. The measured response was compared to the
predicted response to validate the optimal values.
3. Results and discussion
3.1. Screening experiments and one-at-a-time variation of factors
3.1.1. The carbon source
As shown in Fig. 1a, the values of the MPA titers were the
highest with the carbon sources of glucose, fructose, glycerol,
mannitol, xylose and sorbitol. All the carbon sources in Fig. 1a were
used at an identical initial concentration of 10 g/L. The average
values of the MPA titer was the highest with glucose, although
statistically not signiﬁcantly different relative to the other carbon
sources noted earlier. There was no growth and MPA production on
carboxymethyl cellulose (CMC) (Fig. 1a). Sorbitol yielded the
highest biomass concentration relative to the other carbon sources
(Fig. 1a). As the objective was the production of MPA, glucose was
selected as the carbon source of choice. The equally high titers of
MPA with several of the carbon sources (Fig. 1a) suggest that the
carbon source per se did not directly contribute to the synthesis of
MPA.
The effects of the initial concentration of glucose on the
production of MPA and biomass were tested. The results are shown
in Fig. 1b. An increase in concentration of glucose over the range of
10–100 g/L resulted in a progressive increase in the ﬁnal
concentration of the biomass. This notwithstanding, a distinct
peak in the concentration of MPA was seen at a glucose
concentration of 60 g/L (Fig. 1b). Therefore this concentration
was taken as the optimal value. The results in Fig. 1b suggest that
the production of MPA is not growth associated, as expected for a
secondary metabolite. At 60 g/L initial glucose concentration, the
MPA titer was 314  25 mg/L.
3.1.2. The nitrogen source
The inﬂuence of the different nitrogen sources on the
production of biomass and MPA is shown in Fig. 1c. All the
nitrogen sources were tested at an initial concentration of 10 g/L.
The carbon source was glucose at an initial concentration of 60 g/L.
The organic nitrogen sources proved to be distinctly better than the
inorganic nitrogen source of ammonium nitrate (Fig. 1c) for the
production of the biomass and the MPA. Tryptone yielded the
highest ﬁnal biomass concentration, but peptone yielded a higher
average value of the MPA titer of 521 38 mg/L. Although the MPA
titers obtained with tryptone and peptone were not signiﬁcantly
different, the biomass speciﬁc MPA production was higher with
peptone relative to tryptone. (The biomass concentration obtained
with peptone was about 69% of the biomass concentration
obtained with tryptone as the nitrogen source; Fig. 1c.) In view
Table 2
Experimental setup and results for the central composite design matrix.
Run Glucose (g/L) Peptone (g/L) Methionine (g/L) Glycine (g/L) Predicted MPA (mg/L) Measured MPA (mg/L)
1 60 20 1.5 8 1441.9 1388.4
2 80 30 1.0 8 1548.9 1603.1
3 80 30 2.0 4 1448.1 1493.0
4 60 20 1.5 6 1552.3 1550.6
5 60 20 1.5 6 1552.3 1537.1
6 80 30 1.0 4 1462.0 1456.0
7 80 30 2.0 8 1632.7 1560.1
8 40 20 1.5 6 1405.9 1432.7
9 60 30 1.5 6 1617.9 1618.9
10 60 20 1.5 6 1552.3 1585.3
11 80 10 1.0 8 1395.8 1398.3
12 80 10 1.0 4 1300.1 1300.6
13 40 30 2.0 4 1544.6 1547.1
14 60 20 1.5 6 1552.3 1580.2
15 80 10 2.0 8 1341.5 1405.2
16 40 10 2.0 4 1275.6 1224.1
17 80 10 2.0 4 1148.1 1118.5
18 40 10 2.0 8 1114.2 1125.3
19 40 10 1.0 8 1143.3 1101.0
20 60 20 1.5 6 1552.3 1575.0
21 60 20 1.5 6 1552.3 1578.5
22 40 30 2.0 8 1374.4 1376.6
23 60 20 1.5 4 1479.1 1501.6
24 60 20 2.0 6 1599.2 1628.5
25 60 10 1.5 6 1406.8 1375.0
26 60 20 1.0 6 1620.7 1560.5
27 40 30 1.0 4 1533.3 1472.3
28 80 20 1.5 6 1483.8 1426.2
29 40 10 1.0 4 1402.4 1480.0
30 40 30 1.0 8 1265.5 1300.2
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the sources tested.
The effects of the initial concentration of peptone on the
production of MPA and biomass were tested (Fig. 1d). In the
peptone concentration range of 10–40 g/L, the ﬁnal biomass
concentration was not substantially affected by peptone
(Fig. 1d). Nevertheless, a distinct peak occurred in the MPA titer
at an initial peptone concentration of 20 g/L (Fig. 1d). Therefore,
peptone at an initial concentration of 20 g/L was taken to be the
optimal nitrogen sources.
3.1.3. The phosphorous source
The effect of the type of the phosphorous (P) source on the
production of the biomass and MPA is shown in Fig. 1e. There were
no particularly substantial differences in the performance of the
four P-sources. All the P-sources provided phosphorous in the form
of phosphate. As all the P-source were used at the same
concentration of 6 g/L and the molar masses of the source salts
were different, the concentration of phosphate in media formu-
lated with the different salts were slightly different. (The molar
concentrations of phosphate were in the range of 34.5–50.0 mM)
These small differences in the concentration of phosphate did not
cause clear distinctions in the ﬁnal concentrations of the biomass
and MPA (Fig. 1e).
In view of these results, potassium dihydrogen phosphate
(KH2PO4) was arbitrarily selected as the preferred source of
phosphorus. Further experiments were carried out with different
initial concentrations of this P-source to identify its optimal level.
The results are shown in Fig. 1f. The ﬁnal biomass concentration
generally increased with the increasing initial concentration of
phosphate, but beyond a KH2PO4 concentration of 6 g/L there wasbarely any impact of the concentration on the titer of MPA (Fig. 1f).
Therefore, a KH2PO4 concentration of 6 g/L was taken as optimal.
3.1.4. The precursors
In separate experiments, different initial concentration of
methionine and glycine were evaluated for their possible impact
on the production of the biomass and MPA. The results are shown
in Fig. 2. Increasing concentration of methionine in the range of 0–
3 g/L barely had any effect on the ﬁnal biomass concentration
(Fig. 2a), but strongly impacted the production of MPA. The MPA
titer peaked at a methionine concentration of 1.5 g/L (Fig. 2a). In
these experiments the glycine concentration was ﬁxed at 2 g/L.
Based on the data in Fig. 2a, a methionine concentration of 1.5 g/L
was taken as optimal.
An increase in the initial concentration of glycine from 0 to 6 g/L
strongly enhanced the MPA titer, but not the biomass concentra-
tion (Fig. 2b). Higher concentrations (>6 g/L) of glycine actually
caused some decline in the MPA titer (Fig. 2b). Therefore, a glycine
concentration of 6 g/L was taken as optimal. In these experiments
the methionine concentration was always 1.5 g/L.
3.1.5. The initial pH and the incubation temperature
The effect of the initial pH on the production of MPA is shown in
Fig. 3a. An initial pH of 5 clearly maximized the MPA titer relative to
the other pH values. Therefore, a pH of 5 was taken as optimal. An
incubation temperature of 25 C proved to be best for maximizing
the production of MPA (Fig. 3b) and was taken to be optimal.
Thus, based on one-at-a-time variation of the speciﬁed
fermentation parameters, the optimal values for maximizing the
titer of MPA (1232 mg/L) in a 12-day fermentation were as follows:
an initial pH of 5.0; an incubation temperature of 25 C; an
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L; the initial concentrations of glucose, peptone and KH2PO4 at
60 g/L, 20 g/L and 6 g/L, respectively; and the initial concentrations
of methionine and glycine at 1.5 g/L and 6 g/L, respectively.
3.2. Central composite design
Response surface methodology using central composite design
was employed to determine the optimal levels of the four selected
factors that affected MPA production. The relevant factors were theinitial concentrations of glucose, peptone, methionine and glycine.
Each factor was tested at three levels (Table 1). The center point
levels were kept at the values found to be optimal via the one-at-a-
time variation of factors. The other media components and the
fermentation conditions were kept ﬁxed at the following values: a
temperature of 25 C; a fermentation duration of 12 days; an initial
pH of 5.0; an agitation speed of 200 rpm; the KH2PO4 concentra-
tion of 6 g/L; the MgSO47H2O concentration of 1 g/L; and the
earlier speciﬁed trace element solution at 1 mL/L. A total of 30 runs
(each in duplicate) were carried out with the values of the factors
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concentration) of the fermentations are shown in Table 2.
The response surface model was as follows:
MPA mg=Lð Þ ¼ 1552:34 þ 38:98A þ 105:53B  10:76C
 18:62D þ 7:74AB  6:29AC þ 88:69AD
þ 34:51BC  2:20BD þ 24:42CD  107:00A2
 39:96B2 þ 57:61C2  91:86D2 ð1Þ
Where A (g/L) is the concentration of glucose, B (g/L) is the
concentration of peptone, C (g/L) is the concentration of
methionine and D (g/L) is the concentration of glycine.
The maximum MPA concentration of 1629 mg/L was measured
in run 24 (Table 2). The predicted MPA titer for this run was
1599 mg/L, or within  2% of the measured value (Table 2). The
ANOVA of the response surface model (Eq. (1)) is shown in Table 3.
The F-value for the model (i.e. Eq. (1)) was >14 (Table 3), suggesting
that the model was signiﬁcant and the probability of the F-value of
the model being due to experimental noise was less than 0.01%
(Table 3). The initial concentrations of glucose and peptone had a
signiﬁcant effect on the response, but not the initial concentrations
of methionine and glycine (Table 3). However, glycine and glucose
interacted to signiﬁcantly affect the response (Table 3). Similarly,
the interactive effect of peptone and methionine was signiﬁcant
(Table 3,P < 0.05). The determination coefﬁcient (R2) of the model
(Eq. (1)) was 0.9289, therefore the model could explain >92% of the
variation in the predicted response of the MPA concentration.
The response surface plots in Fig. 4 illustrate the effects of pair-
wise combination of the four factors, on the response of MPA
concentration. In generating these plots, the ﬁxed factors were
kept at their center point levels (Table 1). The plots in Fig. 4 providea visual indication of how any two factors interactively affected the
response. The center points of the contour plots (not shown)
corresponding to Fig. 4 were used to identify the following values
of the optimum concentrations (g/L): glucose 66, peptone 30,
methionine 2, and glycine 6.3.
3.2.1. Validation of the response surface model
Validation runs were carried out with the values of the factors
ﬁxed at the above identiﬁed optimal levels. The measured response
was compared to the model (Eq. (1)) predicted response. The
measured MPA concentration (Fig. S2) under the optimized
conditions was 1737.2  54.5 mg/L. For the same conditions, the
model predicted concentration was 1704.2 mg/L. Therefore, the
model prediction agreed with measured data within  2% of the
measured value.
3.3. A comparison of the optimization approaches
The optimal values of the factors obtained by the two methods
of optimization were different in terms of some of the key
constituents of the medium (i.e. glucose, peptone, methionine and
glycine). The CCD-optimized medium was richer than the
conventionally optimized medium in terms of the concentrations
of these key components. Nevertheless, the CCD-optimized
medium yielded an MPA titer of 1737  55 mg/L, a value nearly
40% greater than the peak MPA titer of 1232  90 mg/L attained
using the conventionally optimized medium and nearly 9-fold
greater than the titer (196  18 mg/L) achieved in unoptimized
medium (glucose 10 g/L, glycine 2 g/L, methionine 0.5 g/L, KH2PO4MPA.
Table 3
Analysis of variance (ANOVA) for the response surface model (Eq. (1)).
Source SS DF MS F-value P-value (Prob > F)
Model 1.137  105 14 43,833.28 14.01 <0.0001
Glucose (A) 27,352.04 1 27,352.04 8.74 0.0098
Peptone (B) 2.004 105 1 2.004 105 64.06 <0.0001
Methionine (C) 2082.97 1 2082.97 0.67 0.4273
Glycine (D) 6237.81 1 6237.81 1.99 0.1784
AB 958.14 1 958.14 0.31 0.5882
AC 632.84 1 632.84 0.20 0.6593
AD 1.258  105 1 1.258  105 40.22 <0.0001
BC 19,054.45 1 19,054.45 6.09 0.0261
BD 77.09 1 77.09 0.025 0.8774
CD 9538.21 1 9538.21 3.05 0.1013
A2 2992.48 1 2992.48 9.56 0.0074
B2 4137.62 1 4137.62 1.32 0.2682
C2 8598.97 1 8598.97 2.75 0.1181
D2 21,863.37 1 21,863.37 6.99 0.0184
Residual 46,936.58 15 3129.11
Lack of ﬁt 45,072.33 10 4507.23 12.09 0.0066
Pure error 1864.24 05 372.85
Cor. Total 6.606  105 29
SS—Sum of squares; DF—degrees of freedom; MS—mean sum of squares.
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Further the product was conﬁrmed as MPA by mass spectroscopy,
m/z: 343.11 (Figs. S3, S4). These differences were attributed to the
ability of the CCD-based optimization to account for the interactive
effects of the experimental factors on the response (i.e. the MPA
titer) [27–29]. Unlike the conventional method, the CCD-based
method was statistically sound. By providing a response surface
model (Eq. (1)), the CCD-based optimization enabled theFig. 4. Response surface plots for the interactive effects of the following on the production
L glycine; glucose and methionine (b) at 20 g/L peptone and 6 g/L glycine; glucose and glyc
L glucose and 6 g/L glycine; peptone and glycine (e) at 60 g/L glucose and 1.5 g/L methion
All other concentrations are in g/L.prediction of the MPA titer for any combination of values of the
factors within the experimental space.
3.4. A comparison with the literature
The MPA titers reported in the literature [7] for the batch and
continuous submerged cultures of the various strains of
P. brevicompactum are summarized in Table 4.
The highest reported titer of 5.91 g/L was obtained in shake
ﬂasks in an optimized medium using the strain P. brevicompactum
ATCC 16024 [30] (Table 4). For the same strain, grown in the same
optimized medium, the titer was reduced to 2.31 g/L in a 5 L
conventional stirred batch bioreactor (Table 4). The mycelial
biomass accumulated at the bioreactor walls and the impeller and
this made control of the pH and dissolved oxygen difﬁcult [30].
Shear associated-damage to the mycelium in the stirred bioreactor
possibly contributed to its poor performance relative to the shake
ﬂasks [30]. For the same strain and medium, the cultivation in a 5 L
rotating ﬁbrous bed bioreactor with the biomass immobilized in
the bed improved control of the fermentation conditions and the
MPA titer increased to 5.7 g/L (Table 4), or fairly close to the results
of the shake ﬂask culture [30]. Thus, the same fungal strain in the
same optimized medium can give quite different MPA titers
depending on the kind of bioreactor system used. In comparison
with the shake ﬂask data of Xu and Yang [30], the MPA titer
obtained by Ozaki et al. [31] with the same strain (ATCC 16024) was
only 1.7 g/L (Table 4), presumably because of the different media
compositions used in these studies [31]. The titer in the present
study was 1.73 g/L, or comparable to value reported by Ozaki et al.
[31] for the wildtype strain ATCC 16024. The use of a mutant of the of mycophenolic acid (MPA): glucose and peptone (a) at 1.5 g/L methionine and 6 g/
ine (c) at 20 g/L peptone and 1.5 g/L methionine; peptone and methionine (d) at 60 g/
ine; methionine and glycine (f) at 60 g/L glucose and 20 g/L peptone. MPA is in mg/L.
Table 4
Mycophenolic acid production in various submerged fermentation processes using P. brevicompactum strains.a
Process Microorganism Fermentation time (h) MPA concentration (g/L) Reference
Shake ﬂask (250 mL) batch culture P. brevicompactum ATCC 16024 336 1.7 [31]
P. brevicompactum No. 5-1b 336 5.3 [31]
P. brevicompactum ATCC 16024 240 5.91 [30]
P. brevicompactum MUCL 19011 280 1.38 [7]
P. brevicompactum MUCL 19011c 280 3.63 [7]
P. brevicompactum MTCC 8010 280 1.73 This work
Bioreactor (5 L) batch culture P. brevicompactum ATCC 16024 264 2.31 [30]
Bioreactor (2 L) batch culture P. brevicompactum MUCL 19011 240 1.37 [7]
Bioreactor (2 L) continuous cultured P. brevicompactum MUCL 19011 120 1.46 [7]
Rotating ﬁbrous bed bioreactor (5 L)e P. brevicompactum ATCC 16024 338 5.70 [30]
a Adapted from Ardestani et al. [7].
b This was a mutant of the strain ATCC 16024 [31].
c Treated with growth stimulants (mixed amino acids from enzymatically hydrolyzed casein).
d In steady-state operation.
e Immobilized biomass culture.
84 G. Patel et al. / Biotechnology Reports 11 (2016) 77–85strain ATCC 16024 (the strain No. 5-1 in Table 4), increased the MPA
titer by nearly 3-fold relative to the wildtype [31].
The differences in the attainable MPA titers are at least partly
strain related. For example, using the strain MUCL 19011, Ardestani
et al. [7] never exceeded a titer of 3.63 g/L in shake ﬂasks and in the
batch and continuous operational modes of a stirred tank
bioreactor (Table 4). Although in the present study a titer of
1.73 g/L was comparable to the shake ﬂask data of Ozaki et al. [31]
for a wildtype strain, the MPA productivity in the present work was
20% higher at 0.006 g L1 h1 compared to a productivity of 0.005
g L1 h1 for shake ﬂask cultures of Ozaki et al. [31]. This was
because of the different times at which the reported titers were
achieved (Table 4).
4. Conclusion
For a 12-day batch culture (an initial pH of 5.0, an incubation
temperature of 25 C, and an agitation speed of 200 rpm), the
optimal medium composition identiﬁed via the conventional one-
at-a-time variation of factors was different to the optimal
composition identiﬁed through the central composite design of
experiments. Using the conventional method, the composition was
as follows (g/L): (1) glucose 60, peptone 20, KH2PO4 6, methionine
1.5, and glycine 6.0. Based on the CCD method, the optimal
composition was as follows (g/L): glucose 66, peptone 30, KH2PO4
6, methionine 2, and glycine 6.3. In addition, both the optimized
media contained equal levels of MgSO47H2O (1 g/L) and a trace
element solution of a speciﬁed composition (1 mL/L). The CCD-
optimized medium was richer than the conventionally optimized
medium in concentrations of the key components of glucose,
peptone, methionine and glycine. The CCD-optimized medium
yielded an MPA titer of 1737  55 mg/L, or 40% higher than the
conventionally optimized medium. Therefore, the CCD-based
optimization was concluded to be superior to the conventional
method. The CCD-optimization had the other important advantage
of being statistically robust [27,32]. Unlike the conventional
method, the CCD-based method provided a response surface
model which could be used to predict the MPA titers for a wide
range of values of the relevant factors.
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